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Purpose.Dental hygienists, dentists, and other workforce providers who depend upon their hands for employment are acutely aware
of the need to protect their hands to ensure a successful career. Recent research has suggested that smokingmay be protective of hand
osteoarthritis.Thepurpose of this study is to determine the association between smoking andHeberden’s nodes.Methods.Data from
theOsteoarthritis Initiative were used in a cross-sectional, secondary data analysis of self-reported current smoking/never smoking
and the presence/absence of Heberden’s nodes, the hard enlargements of the joints nearest the fingertips (distal interphalangeal
joints). Analyses included descriptive statistics, Chi-square associations with Heberden’s nodes, and logistic regressions. Results. In
adjusted analysis, smoking had an adjusted odds ratio for Heberden’s nodes of 0.832 [95% confidence interval: 0.60, 1.14] which
failed to reach significance (𝑃 = .2488). In the selected model, females were more likely than males to have Heberden’s nodes;
non-Hispanic Blacks were less likely than non-Hispanic Whites to have Heberden’s nodes; and older age groups were more likely
than the youngest age group to have Heberden’s nodes. Conclusion. Smoking did not provide protection against Heberden’s nodes
in this study of US participants in the Osteoarthritis Initiative.
1. Introduction
Osteoarthritis is themost common formof arthritis involving
entire joints (cartilage, joint lining, ligaments, and underlying
bone) [1] and mainly affecting the axial skeleton and large
appendicular joints [2]. Over 21% of US adults (an estimated
46.4 million) have osteoarthritis [3]. When considering life-
time risk of symptomatic osteoarthritis, researchers reported
nearly 50% of adults will develop osteoarthritis by age of
85 years [4]. Many of the epidemiological researchers for
osteoarthritis have considered various predictors and asso-
ciated morbidities involved with osteoarthritis. It has been
associated with body mass index [5], low Vitamin D [6, 7],
and increased consumption of soft drinks in men [8] and
in women with limited milk consumption [9], not breast-
feeding [10], and giving birth [10]. Inconclusive and contra-
dictory associations have been reported concerning associ-
ations of osteoarthritis and sex in which some researchers
found positive associations [7, 11, 12] while others did not [13]
and with smoking in which some researchers found positive
associations [14], others found protective associations [15, 16],
and others did not find any association [13].
Hand osteoarthritis is highly prevalent, impacts function,
and leads to considerable pain, stiffness, and disability [17, 18].
There are 26.2% of women and 13.4% of men aged 71 years
and above who have hand osteoarthritis [19]. In an age-sex
standardized analysis, researchers reported an incidence of
hand osteoarthritis of 100/100,000 person-years (as compared
with 88/100,000 person-years for the hip) [20]. Nevertheless,
epidemiological studies of hand osteoarthritis are limited
[18, 19]. Hands often develop hard tissue enlargements. If the
enlargements involve the joints nearest the fingertips, which
are the distal interphalangeal joints, the enlargements are
termedHeberden’s nodes. If the enlargements involve the 2nd
joints from the fingertips, which are the proximal interpha-
langeal joints, the enlargements are termedBouchard’s nodes.
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Hand osteoarthritis has been defined as the pres-
ence of (1) hand pain/aching/stiffness; (2) at least 2 bony
nodes on the 2nd/3rd distal/proximal interphalangeal/first
trapeziometacarpal (base of thumb) joints; (3) less than
3 swollen metacarpophalangeal joints; and (4) at least 2
Heberden’s nodes, or deformity of at least 2 of the 2nd/3rd dis-
tal/proximal interphalangeal/first trapeziometacarpal joints
[21]. The disease process for hand osteoarthritis is poorly
understood, and it is yet to be determined if metabolic
factors are involved [18]. Some researchers have indicated that
the hard tissue enlargements on the distal interphalangeal
joints, Heberden’s nodes, may be genetic markers for general
arthritis [22]. If this is the case, an environmental factor, such
as smoking, may have an epigenetic role [23].
Smoking is a potentially modifiable risk factor for many
conditions and diseases including lung cancer and other
cancers, coronary heart disease and other heart diseases,
cerebrovascular disease and other vascular diseases, diabetes
mellitus, respiratory diseases (including chronic obstructive
pulmonary disease), rheumatoid arthritis, sudden unex-
plained infant death, inflammation, adverse effects on the
immune system, and bone health [24]. Smoking causes more
than 480,000 deaths annually in the US [24]. In a report of
the U.S. Department of Health and Human Services (2014)
[24], the authors indicated that smoking harms nearly every
organ in the body.There is a biological plausibility that smok-
ing is associated with hand osteoarthritis and one feature
in particular—Heberden’s nodes. Previous researchers have
reported conflicting results as to the association of smoking
and osteoarthritis in general and smoking with Heberden’s
nodes [2]. The purpose of this study is to determine the
association of smoking and Heberden’s nodes.
2. Materials and Methods
2.1. Data Source. The data used in the preparation of
this paper were obtained from the Osteoarthritis Initiative
(OAI) database, which is available for public access at
http://www.oai.ucsf.edu/. Specific datasets used were from
the version 0.2.2 (2009) physical exam/measurements file:
subject characteristics file; risk factors file; joint symp-
toms/function file; biomarkers file; and medical history file.
The version V21 (2015) enrollee file was also used.
The researchers for the OAI conducted a longitudinal
study at four clinical centers (Brown University School of
Medicine/Memorial Hospital of Rhode Island in Pawtucket;
The Ohio State University in Columbus; University of Pitts-
burgh in Pittsburgh; and University of Maryland/John Hop-
kins University in Baltimore) and one data collection center
(University of California, San Francisco School of Medicine)
in a design to develop public domain osteoarthritis research
through the development andmaintenance of an osteoarthri-
tis natural history database containing biochemical, genetic,
and imaging biomarkers for osteoarthritis [25]. Participant
exclusion criteria included refusal to sign informed con-
sent documents, self-reported prevalent rheumatoid arthritis,
bilateral total knee replacement or expected bilateral knee
replacement within 3 years, severe joint space narrowing in
both knees determined at baseline, pregnancy, the use of
more than a single cane to aid in walking for more than
50% of the time, conditions which might cause an inability
to participate in the entire length of the study, potential move
from the clinic areawithin 3 years, enrollment as a participant
in a double-blind randomized controlled study, inability to
have a 3.0 Tesla MRI, or inability to provide a blood sample
[25]. There were 4769 participants, aged 45–79 years, in the
source data from which our sample was drawn. Additional
documentation describing various aspects of the design and
methods of the OAI is available at the OAI online website
(http://www.oai.ucsf.edu/).
2.2. Participant Eligibility. Participants for this study were
included if they (1) were current or never smokers; (2)
provided a response to the question about any obvious
hard bumps on the joints nearest to the fingertips; and
(3) had complete data on the other variables of interest in
the study (age, sex, race/ethnicity, alcohol use, educational
level, comorbidities, height, weight, family history, physical
summary score, and knee osteoarthritis). Participants were
excluded if they were former smokers or if they did not
provide a response concerning any obvious hard bumps on
the joints nearest to the fingertips or had incomplete data on
the other variables of interest in the study. From the 4769
participants in the OAI, there were 2723 participants who
had data on all of the variables of interest and were therefore
eligible for this study.
2.3. Key Dependent Variable. The presence or absence (yes,
no) of Heberden’s nodes was the key dependent variable. It
was determined by the self-report of the participant of any
obvious hard bumps on the joints nearest to the fingertips.
This was a question asked during the initial eligibility inter-
view.
2.4. Key Independent Variable. Thekey independent variable
is smoking (current, never). Never smoking was determined
by the self-report of the participant that he or she had never
smoked 100 cigarettes (5 packs) in his or her life. A follow-
up question of current smoking status identified current
smokers. Former smokers were excluded from the study.
2.5. Other Variables. Also included in the analyses were sex
(male, female); age (45 to less than 56 years, 56 to less
than 66 years, and 66 years and above); race/ethnicity (non-
Hispanic White, non-Hispanic Black, and Hispanic/other);
education (high school graduate or less, more than high
school graduate); body mass index (less than 25, 25 to less
than 30, and 30 and above); Charlson index (0, 1, and
above); and mother/father/sister/brother having had knee
replacement (yes, no). The presence of knee osteoarthritis
was determined by the right-side baseline radiographs scored
on the composite quasi-Kellgren and Lawrence graded as (0)
normal, (1) possible, (2) mild, (3) moderate, and (4) severe
OA. Physical summary scores (categorized as quartiles)
from the Medical Outcomes Study Short Form-12 version 2
physical summary scale were also included.
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2.6. Statistical Analyses. The analyses for the study were
conducted using SAS 9.2 software (SAS Institute, Chicago,
IL). The data were analyzed for a description of the sample
characteristics, bivariate analyses of the variables by Heber-
den’s nodes, and logistic regression on Heberden’s nodes.
Unadjusted and adjusted logistic regressions were completed
using the eligible participants as the domain in the analyses.
3. Results and Discussion
The sample consisted of 2723 participants. There were 59.7%
(1625) females, 78.9% (2148) non-Hispanic Whites, 19.0%
(516) non-Hispanic Blacks, and 2.2% (59) Hispanic/other. In
terms of age groups, there were 38.5% (1047) participants
aged 45 to less than 56 years; 30.4% (827) aged 56 to less
than 66 years; and 31.2% aged 66 years and above.There were
26.0% with a body mass index below 25 (normal weight);
38.7% with a body mass index between 25 and less than
30 (overweight); and 35.3% with a body mass index of 30
or above (obese). Most participants (76.2%) had a Charlson
index of 0 and an education above high school (84.1%)
and did not have a mother/father/sister/brother who had a
knee replacement. There were 18.8% of participants who had
a normal right knee radiographic evaluation and 5.5% of
participants who had a severe right knee radiographic eval-
uation. There were 30.1% (819) of participants who reported
having Heberden’s nodes and 11.4% (310) of participants who
reported current smoking. The Medical Outcomes Study
Short Form-12 version 2 physical summary scale quartile cut-
points were 43.06, 51.24, and 56.14 for 25%, 50%, and 75%,
respectively. Details of the analyses are presented in Table 1.
Table 2 includes the results of the Chi-square analyses
between Heberden’s nodes and the variables. Smoking, the
key independent variable of interest, was significantly related
to Heberden’s nodes (𝑃 = .0006). Other significant relation-
ships with Heberden’s nodes were with sex, race/ethnicity,
age, body mass index, right knee radiographic evaluation,
mother/father/sister/brother who had a knee replacement,
education, and the Medical Outcomes Study Short Form-12
version 2 physical summary scale quartiles. Charlson index
and alcohol usage failed to reach significance in association
with Heberden’s nodes.
Table 3 includes the results of the logistic regressions
of smoking on Heberden’s nodes. In unadjusted analysis,
current smokers were less likely to have Heberden’s nodes
than never smokers (less than 5 packs/lifetime). The odds
ratio for current smokers, as compared with never smokers,
was 0.61 (95% confidence interval: 0.46, 0.81; 𝑃 = .0007).
When the other significant variables were included in the
model, smoking was attenuated to an adjusted odds ratio
of 0.83 [95% confidence interval: 0.60, 1.14] which failed to
reach significance (𝑃 = .2488). In the selectedmodel, females
were more likely than males to have Heberden’s nodes; non-
Hispanic Blacks were less likely than non-Hispanic Whites
to have Heberden’s nodes; older age groups were more likely
than the youngest age group to haveHeberden’s nodes; people
in the lower quartiles on the Medical Outcomes Study Short
Form-12 version 2 physical summary scale were more likely
to have Heberden’s nodes than people in the highest quartile;







Yes, current 310 11.4





Non-Hispanic White 2148 78.9
Non-Hispanic Black 516 18.9
Hispanic/other 59 2.2
Age in years
45 to <56 1047 38.5
≥56 to <66 827 30.4
≥66 849 31.2
Body mass index
<25 (normal weight) 709 26.0
≥25 to <30 (overweight) 1054 38.7
≥30 (obese) 960 35.3
Right knee radiographic evaluation
Normal 512 18.8











High school or less 434 15.9





15 and above 86 3.2
1Medical Outcomes Study Short Form-12
Quartile 1 655 24.1
Quartile 2 668 24.5
Quartile 3 643 23.6
Quartile 4 757 27.8
1Medical Outcomes Study Short Form-12 version 2 physical summary scale
quartile cut-points: 25% = 43.06; 50% = 51.24; and 75% = 56.14.
and people with a BMI of 30 and above were less likely to have
Heberden’s nodes than people with a BMI of less than 25.
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Table 2: Chi-square analysis of Heberden’s nodes by the variables,
Osteoarthritis Initiative data.




Yes, current 67 21.6 243 78.4
Never (<5 packs/lifetime) 752 31.2 1661 68.8
Sex <.0001
Female 647 39.8 978 60.2
Male 172 15.7 926 84.3
Race/ethnicity <.0001
Non-Hispanic White 706 32.9 1442 67.1
Non-Hispanic Black 90 17.4 426 82.6
Hispanic/other 23 39.0 36 61.0
Age <.0001
45 to <56 187 17.9 860 82.1
≥56 to <66 269 32.5 558 67.5
≥66 363 42.8 486 57.2
Body mass index <.0001
<25 (normal weight) 247 34.8 462 65.2
≥25 to <30 (overweight) 330 31.3 724 68.7
≥30 (obese) 242 25.2 718 74.8
Right knee radiographic
evaluation .0190
Normal 124 24.2 388 75.8
Possible osteoarthritis 288 30.1 669 69.9
Mild 178 32.7 366 67.3
Moderate 181 32.4 378 67.6
Severe 48 31.8 103 68.2
Family history of
osteoarthritis .0172
Yes 91 36.7 157 63.5
No 728 29.4 1747 70.6
Charlson index .7836
0 621 29.9 1453 70.1
≥1 198 30.5 451 69.5
Education .0017
High school or less 158 36.4 276 63.6
More than high school 661 28.9 1628 71.1
Alcohol use (drinks/week) .1025
0–3 646 31.0 1438 69.0
4–7 104 29.3 251 70.7
8–14 45 22.7 153 77.3
15 and above 24 27.9 62 72.1
1MOS SF-12 quartiles .0037
Quartile 1 218 33.3 437 66.7
Quartile 2 217 32.5 451 67.5
Quartile 3 193 30.0 450 70.0
Quartile 4 191 25.2 566 74.8
1Medical Outcomes Study Short Form-12 version 2 physical summary scale.
The purpose of this study was to explore the association
of smoking and Heberden’s nodes. The results were that the
adjusted odds ratio for smoking on Heberden’s nodes failed
to reach significance (𝑃 = .2337). Interaction analysis with
family history did not change the results. However, female
smokers and female nonsmokers were more likely to have
Table 3: Odds ratios and 95% confidence intervals from logistic







Yes, current 0.61 [0.46, 0.81] .0007
Never (<5 packs/lifetime) Referent
Adjusted model
Smoking .2488
Yes, current 0.83 [0.60, 1.14]
Never (<5 packs/lifetime) Referent
Sex <.0001




Non-Hispanic Black 0.38 [0.29, 0.49] <.0001
Hispanic/other 1.12 [0.61, 2.08] .7094
Age
45 to <56 Referent
≥56 to <66 1.97 [1.57, 2.48] <.0001
≥66 2.81 [2.22, 3.55] <.0001
Body mass index
<25 (normal weight) Referent
≥25 to <30 (overweight) 1.02 [0.81, 1.27] .8988
≥30 (obese) 0.72 [0.57, 0.93] .0105
Right knee radiographic evaluation
Normal Referent
Possible osteoarthritis 1.16 [0.89, 1.52] .2722
Mild 1.22 [0.90, 1.65] .1984
Moderate 1.16 [0.86, 1.58] .3359
Severe 1.17 [0.74, 1.84] .4998
Family history of osteoarthritis
Yes 1.24 [0.92, 1.69] .1625
No Referent
Education
High school or less 1.16 [0.91, 1.50] .2372
More than high school Referent
MOS SF-12 quartiles1
Quartile 1 1.53 [1.18, 1.98] .0015
Quartile 2 1.40 [1.09, 1.80] .0096
Quartile 3 1.28 [0.99, 1.64] .0577
Quartile 4 Referent
1Medical Outcomes Study Short Form-12 version 2 physical summary scale.
Heberden’s nodes than male nonsmokers (AOR = 2.95 and
3.69, resp.; 𝑃 < .0001); and smokers aged 45–56 years,
smokers aged 56 years and above, and nonsmokers aged
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56 years and above weremore likely to haveHeberden’s nodes
than young nonsmokers (AOR = 1.24, 1.94, 3.00, resp.).
The literature has few studies involving the relationship
between hand osteoarthritis and smoking, [26]. There are
even fewer studies between Heberden’s nodes and smoking
with which we could compare our results. This study’s results
are similar to results of Haara et al. [26] who studied Kellgren
and Lawrence Grade 2 + osteoarthritis in any finger and
smokers who smoked 20 or more cigarettes per day. The
results in that study included an adjusted odds ratio of 0.72
[95% confidence interval: 0.48, 1.09] [26]. In a study of 443
Chuvashian (Russian) men, no association of smoking and
hand osteoarthritis was determined (Chi-square 𝑃 = .49)
[27].
This study’s results are also similar to the risk ratio for
current smoking on hand osteoarthritis in which the adjusted
odds ratio was 0.99 [95% confidence interval: 0.75, 1.31] [28].
The definition for smoking exposure (i.e., current smoking
and never smoking) used by Wilder et al. [28] was the same
as the definition used for this study. However, protective
results of smoking with Heberden’s nodes in women [29]
and protective results of smoking and osteoarthritis in knees
and large joints are also reported in the literature [15, 16,
30]. It has been suggested that there is a differential effect
of nicotine on human chondrocyte glycosaminoglycan and
collagen synthesis [31].
3.1. Plausible Biological Mechanism. It has been reported
that the relationship of smoking with Heberden’s nodes
and osteoarthritis is variable [2] and that the etiology of
osteoarthritis may be different at different body sites [16].
Additionally, the effects of nicotine may also be different at
different body sites [16]. Although nicotine was shown to be
beneficial to chondrocyte metabolism, it was also shown to
destroy chondrocytes at the intervertebral disk, but not at the
knee [31–33].
4. Conclusion
Workforce losses due to hand osteoarthritis would place a
great burden on society. This is particularly true for health-
care access to care issues in which certain professions require
repetitive motions (such as with dental hygiene). The public
health impact is a concern, especially for high risk, special
needs populations. Hand osteoarthritis and its implications
may become a factor in recruitment to various professions
and workforce numbers. Determining and understanding
factors associated with hand osteoarthritis and factors not
implicated with hand osteoarthritis are important for indi-
viduals and for workforce preparation.
We failed to reject the null hypothesis of no difference
in the number of Heberden nodes among individuals who
smoke and individuals who do not smoke; we did not provide
any clear evidence of a protective effect of smoking. These
findings are similar to the findings of many studies of smok-
ing and hand osteoarthritis but are not similar to previous
findings concerning Heberden’s nodes in which smoking was
protective.The implications of this study are that smoking has
not shown any beneficial effects in protecting the hands.With
current knowledge of the harms of smoking, this study adds
to themounting knowledge in the literature that there are few
benefits and many known harms of smoking.
Additional Points
The researchers of the OAI intended to provide a wide
longitudinal database for public use; it was not intended to be
nationally representative. As a result, the number of smokers
in the study is not representative of the nation (11.4% in the
sample as compared with 17.8% nationally) [34]. This was
a limitation of the available data. There are limited studies
available to determine if the smoking exposure in studying
osteoarthritis should be current smoking, as is needed for
studies of myocardial infarctions, or if it should be pack-
years/total duration, as is needed for studies of lung cancer
[28]; therefore this limitation also applies to this study.
Ethical Approval
This cross-sectional study, a secondary data analysis (nonhu-
man subject research) of the OAI data, was acknowledged
by the West Virginia University Institutional Review Board
(Protocol no. 1509861595) and did not include experimenta-
tion involving human subjects or animals. TheWest Virginia
University Institutional Review Board does not approve nor
disapprove research which involves nonhuman subjects, such
as this project; however the members of the Board review the
protocol, acknowledge the review, and keep the protocol on
file. The research was conducted in full accordance with the
World Medical Association Declaration of Helsinki.
As with any study which relies upon self-report, there is
the possibility of misclassification due to inaccurate report
of smoking, Heberden’s nodes, or the other self-reported
variables. Self-reported data remains a weakness of all cross-
sectional studies. However, overall, the large sample made it
possible to include many additional variables in the model
in the explanation of the relationship of smoking and Heber-
den’s nodes. Additionally, the data were quality data intended
for secondary data analysis.
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